1. OP33 Results of a randomised controlled trial to evaluate Interleukin 1 blockade with anakinra in patients with acute severe ulcerative colitis (IASO). (30th January 2023) Authors: Raine, T; Vaja, S; Subramanian, S; Brezina, B; Probert, C S; Steel, A; Lofthouse, M; Speight, R A; Lamb, C; Sebastian, S; Kane, J; Thut, J; Din, S; Arnott, I; Smith, L; Galea, J; Hendy, P; Flores, L; Selinger, C; Onoviran, F Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P093 CD4 T-cell transcriptome analysis at baseline predicts clinical remission to anti-TNF agents in ulcerative colitis (UC). (25th January 2019) Authors: Subramanian, S; Rainbow, L; Gemmell, M; Hough, R; Haldenby, S; Gureviciute, A; Lofthouse, M; Martin, K; Probert, C Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S132 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗